IGF2BP2 and hepatocellular carcinoma: To explore the biological roles of p62/IMP2 in HCC progression, p62/IMP2 was knocked out in a well-differentiated liver cancer cell line (HepG2) and in the poorly differentiated liver cancer cell line (SNU449).